Among them, ALT is an enzyme that involves the process of amination between glutamic acid and oxaloacetate; it is found mostly among cytosol of hepatocytes, and serum ALT increased accompanied by apoptosis and injury of hepatocytes (10), that's why it is used as an indicator of liver function to reflect the hepatic inflammation in patients with diverse liver diseases, including NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.